ALHC
Alignment HealthcareBNasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-21
Current thesis
Strong Q1 growth and raised guidance could support a re-rating if Q2 confirms membership, margin, and EBITDA execution. The reported median analyst target is $24.9231, but analyst count is unavailable.
Posture
Constructive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta 0.0.
What can break
Analyst estimate revisions, target changes, and consensus surprise data are unavailable.
Momentum
71
Value
53
Sentiment
51
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $20.00 · Bull $24.90 · Bear $16.50
Data freshness
Prices
As of 2026-07-21
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-21 • Model: HYBRID_IC_RP
AI Memo
As of 2026-07-16 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-21
Investment thesis
As of 2026-07-21
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $24.92
Why
Momentum71 · Δ7d -22.3
Value53 · Δ7d 0.0
Sentiment51 · Δ7d -18.3
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Value · See fundamentals
Momentum
71
26% active weight
Current posture
7d trendSoftening
Δ7d
-22.3
Δ21d
-25.5
Value
53
39% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
+0.9
Sentiment
51
34% active weight
Current posture
7d trendSoftening
Δ7d
-18.3
Δ21d
-3.6
Why this grade
Composite grade B. Momentum 70.7 / Value 52.7 / Sentiment 51.2
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$4.36B
Beta
1.16
Shares Out
206.73M
P/E (TTM) · Derived
-5702.7
P/S (TTM)
1.16
P/FCF (TTM)
27.91
Rev YoY
+33.3%
EPS YoY
-213.8%
Gross Margin
+12.4%
Op Margin
-0.0%
Net Debt
-$239.87M
Current Ratio
1.58
As of 2026-07-21 • Updated nightlySource: Internal modelMethodology